MedTrace Logo

Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting

NCT00714519 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-08-30

No results posted yet for this study

Summary

This study will assess if a clinical trial regarding healing of partial thickness wounds can be executed in nursing homes.

Conditions

  • Partial Thickness Wounds

Interventions

DRUG

Xenaderm® Ointment

Topical, BID or as needed

DRUG

Placebo Comparator

Topical, BID or as needed

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

  • Innes Cargill, PhD · Healthpoint

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-10-31
Completion
2008-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714519 on ClinicalTrials.gov